Literature DB >> 29569323

Real-world observational results from a database of 48 million men in the United States: Relationship of cardiovascular disease, diabetes mellitus and depression with age and erectile dysfunction.

Irwin Goldstein1, Richard Chambers2, WingYu Tang3, Vera Stecher4, Tarek Hassan4.   

Abstract

AIMS: To evaluate the relationship of comorbidities (cardiovascular disease [CVD], diabetes mellitus [DM] and depression) with erectile dysfunction (ED) and age using real-world claims data from 48 million men in the United States.
METHODS: This was a cross-sectional, non-interventional study in men aged ≥18 years using data from the Truven Health MarketScan® and Medicare Supplemental Research Databases from January 2010 to December 2015, with an observational period of January 2011 to December 2014 to allow for 12 months pre- and post-index. Comorbidity rate was compared between ED and non-ED groups by age using the χ2 (bivariate) test. Comorbidity relationship to ED after controlling for categorical variables was assessed using logistic regression analysis.
RESULTS: In all, 48 004 379 men were in the database. Of the 9 839 578 who met the inclusion criteria, 573 313 (6%) were ED patients and 9 266 265 (94%) were non-ED patients. ED diagnosis increased decade to decade from 18-29 years to 50-59 years but decreased from 60-69 years to ≥90 years. ED patients had a higher prevalence of CVD, DM and depression than non-ED patients in all periods (P < .0001). After controlling for potential demographic and baseline confounders, the association between ED and CVD, DM and depression remained significant for each age group beginning at 30-39 years (P < .0001). DISCUSSION: Conversations with patients concerning ED should be comprehensive regardless of patient age, in particular in those who have CVD, DM and/or depression.
CONCLUSIONS: In the real-world setting, ED diagnosis was associated with CVD, DM and depression across age groups, suggesting a need for inquiry about the potential for comorbidities among these men as a preventative measure against potentially serious future events.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29569323     DOI: 10.1111/ijcp.13078

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

1.  Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis.

Authors:  Camilla R Madeira; Fernanda S Tonin; Mariana M Fachi; Helena H Borba; Vinicius L Ferreira; Leticia P Leonart; Aline F Bonetti; Rogerio P Moritz; Angela C L B Trindade; Alan G Gonçalves; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  World J Urol       Date:  2020-05-09       Impact factor: 4.226

2.  A Preliminary Study of Short-Term Sexual Function and Satisfaction Among Men Post-Myocardial Infarction.

Authors:  Asa B Smith; Debra L Barton; Matthew Davis; Elizabeth A Jackson; Jacqui Smith; Daniela Wittmann
Journal:  J Holist Nurs       Date:  2021-08-12

Review 3.  Erectile dysfunction and diabetes: A melting pot of circumstances and treatments.

Authors:  Giuseppe Defeudis; Rossella Mazzilli; Marta Tenuta; Giovanni Rossini; Virginia Zamponi; Soraya Olana; Antongiulio Faggiano; Paolo Pozzilli; Andrea M Isidori; Daniele Gianfrilli
Journal:  Diabetes Metab Res Rev       Date:  2021-09-21       Impact factor: 8.128

4.  On the Relationship Between Erectile Function and Sexual Distress in Men with Prostate Cancer.

Authors:  Lauren M Walker; Pablo Santos-Iglesias
Journal:  Arch Sex Behav       Date:  2020-02-18

5.  Prevalence, Comorbidities, and Risk Factors of Erectile Dysfunction: Results from a Prospective Real-World Study in the United Kingdom.

Authors:  Jim Z Li; Terence A Maguire; Kelly H Zou; Lauren J Lee; Shaantanu S Donde; David G Taylor
Journal:  Int J Clin Pract       Date:  2022-03-20       Impact factor: 3.149

6.  Erectile dysfunction in male lymphoma survivors in a Southeast Asian country.

Authors:  Gin Gin Gan; Diana Leh Ching Ng; Yuen Chwan Leong
Journal:  Singapore Med J       Date:  2022-07       Impact factor: 3.331

7.  Long-Term Aspirin Administration Has No Effect on Erectile Function: Evidence from Adult Rats and Ageing Rat Model.

Authors:  Tao Li; Changjing Wu; Fudong Fu; Wenfeng Xiong; Feng Qin; Jiuhong Yuan
Journal:  Sci Rep       Date:  2019-05-28       Impact factor: 4.379

Review 8.  The Use of Vasoactive Drugs in the Treatment of Male Erectile Dysfunction: Current Concepts.

Authors:  George T Kedia; Stefan Ückert; Dimitrios Tsikas; Armin J Becker; Markus A Kuczyk; Andreas Bannowsky
Journal:  J Clin Med       Date:  2020-09-16       Impact factor: 4.241

9.  Establishment of NOAEL for intracavernous injections of human bone marrow-derived mesenchymal stem cells in rats.

Authors:  Jong Keun Kim; Myoung Jin Jang; Bo Hyun Kim; Ki Ryung Choi; Geehyun Song; Ha Chul Shin; Nayoung Suh; Yong Man Kim; Dalsan You; Tai Young Ahn; Choung-Soo Kim
Journal:  Investig Clin Urol       Date:  2019-12-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.